These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 434491)

  • 21. Comparison of speed of onset of fazadinium, pancuronium, tubocurarine and suxamethonium.
    Blackburn CL; Morgan M
    Br J Anaesth; 1978 Apr; 50(4):361-4. PubMed ID: 26369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. d-Tubocurarine sensitivities of a fast and a slow neuromuscular system of the rat.
    Storella RJ; Riker WF; Baker T
    Eur J Pharmacol; 1985 Nov; 118(1-2):181-4. PubMed ID: 4085548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of myoneural blocking drugs on neuromuscular transmission in infants.
    Robbins R; Donati F; Bevan DR; Bevan JC
    Br J Anaesth; 1984 Oct; 56(10):1095-9. PubMed ID: 6089858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.
    Krieg N; Crul JF; Booij LH
    Br J Anaesth; 1980 Aug; 52(8):783-8. PubMed ID: 6107097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity.
    Bornia EC; Correia-de-Sá P; Alves-Do-Prado W
    Clin Exp Pharmacol Physiol; 2011 Mar; 38(3):164-9. PubMed ID: 21208254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketamine potentiates nondepolarizing neuromuscular relaxants in a primate.
    Tsai SK; Lee C
    Anesth Analg; 1989 Jan; 68(1):5-8. PubMed ID: 2562910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and chronic changes in intra- and extracellular potassium and responses to neuromuscular blocking agents.
    Hill GE; Wong KC; Shaw CL; Blatnick RA
    Anesth Analg; 1978; 57(4):417-21. PubMed ID: 568402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differing interactions between hexamethonium and tubocurarine, pancuronium or alcuronium at the neuromuscular junction.
    Pollard BJ; van der Spek AF
    Br J Anaesth; 1988 Oct; 61(4):419-24. PubMed ID: 2903757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temperature and potency of d-tubocurarine and pancuronium in vitro.
    Farrell L; Dempsey MJ; Waud BE; Waud DR
    Anesth Analg; 1981 Jan; 60(1):18-20. PubMed ID: 7192944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clindamycin enhances a nondepolarizing neuromuscular blockade.
    Becker LD; Miller RD
    Anesthesiology; 1976 Jul; 45(1):84-7. PubMed ID: 937756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of diazepam on neuromuscular transmission and its interaction with non-depolarizing muscle relaxants.
    Jain PD; Pandey K; De M
    Anaesth Intensive Care; 1976 May; 4(2):122-5. PubMed ID: 937720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium.
    Jones RM; Cashman JN; Casson WR; Broadbent MP
    Anesth Analg; 1985 Oct; 64(10):1021-5. PubMed ID: 4041146
    [No Abstract]   [Full Text] [Related]  

  • 37. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents.
    Cashman JN; Jones RM; Vella LM
    Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothermic cardiopulmonary bypass and neuromuscular blockade by pancuronium and vecuronium.
    Buzello W; Schluermann D; Schindler M; Spillner G
    Anesthesiology; 1985 Feb; 62(2):201-4. PubMed ID: 2857541
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuromuscular pharmacology.
    Bush GH; Stead AL; Nightingale DA; Rees GJ; Vivori E; Abbott TR
    Br J Anaesth; 1980 Sep; 52(9):962-4. PubMed ID: 6254549
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the effects of pancuronium and tubocurarine on different muscles of young and old mice.
    Kelly SS; Gertler RA; Robbins N
    Br J Anaesth; 1986 Aug; 58(8):909-14. PubMed ID: 3015178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.